Brompheniramine Maleate Suppliers & Bulk Manufacturers
Available Forms: Tablets / Syrup / Injection
Available Strengths: 4mg, 6mg, 8mg, 12mg/ 5mg
Reference Brands: Dimetapp (USA /EU / UK)
Category:
Allergy Medication
Brompheniramine is a first-generation antihistamine widely used for the relief of allergic conditions. It works by blocking histamine H1 receptors, thereby reducing symptoms such as sneezing, runny nose, watery eyes, itching, and skin rashes. Due to its mild sedative effect, it is often combined with decongestants and cough suppressants in cold and allergy formulations.
Brompheniramine Maleate is available in Tablets / Syrup / Injection
and strengths such as 4mg, 6mg, 8mg, 12mg/ 5mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Brompheniramine Maleate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Brompheniramine Maleate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing